Fritextsökning
Innehållstyper
-
Abbott expands by acquisition
An acquisition gives Abbott a leadership position in another large and growing medical device segment.
-
Prenatal testing breakthrough
For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.
-
Finding your way at the fairs
For details on exhibitors, booths, seminars and the fair map we have gathered the important sites for you.
-
Relax at the After Fair
Round off the first day of the fair by visiting the After Fair. You can reload with entertainment from talented artists such as Patrik Isaksson, The Gentlemen a...
-
Per Hammargren, Sales Director, ICU Scandinavia AB
Why are you going to Scanlab and Biotech Forum?
-
Oro att coronaviruset smittar mellan djur och människor
Forskare vill se studier som klargör om djur smittade med sars-cov-2 kan smitta människor.
-
Billigare och tidigare upptäckt av cancer
Tjugo biomarkörer i stället för en. Ett blod- eller urinprov i stället för biopsi eller röntgen. Och AI som bedömer. Så ska Elypta möjliggöra tidigare diagnostik av cancer.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Digitalisering och kliniska prövningar
Effektivare kliniska prövningar och ny teknologi för dokumentation av behandlingar - Digitaliseringen öppnar många möjligheter. Ola Björkman rapporterar från BIO i San Diego.
-
Almost 150 will leave Coloplast
The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.
-
Astrapreparat bra vid by-pass
En klinisk studie från Uppsala Clinical Research Centre visar fördelar med Astras preparat jämfört med standardbehandlingen.
-
Nya resultat om immunförsvarets reaktion vid svår covid-19
Forskare har identifierat flera celltyper som är centrala vid immunförsvarets reaktion vid covid-19.
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
With their hands on the legal levers
It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
Pronova Biopharma grows
Recently, Norway's Pronova Biopharma announced the creation of new jobs in Denmark
-
Future drugs from Amaryllis
A Danish research team has discovered possibolities to extract drugs fro Amaryllis.
-
Tekniska framsteg i fokus
På det årliga internationella forumet New Horizons in Biologics & Bioprocessing den 17 december på Stockholm Waterfront samlas branschen för att höra om det sen...
-
Welcome to wonderful Copenhagen
Strategically located, the Danish capital is the focal point of one of the most dynamic regions in Northern Europe. Here are some tips on where to spend your ti...
-
International models among science parks
Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Cou...
-
Brighter förlänger erbjudandet
Ger mer tid till Division By Zeros aktieägare att acceptera bolagets köperbjudande.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.